Cargando…
Prolonged inhibition of 5-HT(3) receptors by palonosetron results from surface receptor inhibition rather than inducing receptor internalization
BACKGROUND AND PURPOSE: The 5-HT(3) receptor antagonist palonosetron is an important treatment for emesis and nausea during cancer therapy. Its clinical efficacy may result from its unique binding and clearance characteristics and receptor down-regulation mechanisms. We investigated the mechanisms b...
Autores principales: | Hothersall, J Daniel, Moffat, Christopher, Connolly, Christopher N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831706/ https://www.ncbi.nlm.nih.gov/pubmed/23581504 http://dx.doi.org/10.1111/bph.12204 |
Ejemplares similares
-
5-Hydroxytryptamine (5-HT) Cellular Sequestration during Chronic Exposure Delays 5-HT(3) Receptor Resensitization due to Its Subsequent Release
por: Hothersall, J. Daniel, et al.
Publicado: (2014) -
High-affinity fluorescent ligands for the 5-HT(3) receptor
por: Simonin, Jonathan, et al.
Publicado: (2012) -
Exploring a potential palonosetron allosteric binding site in the 5-HT(3) receptor()
por: Del Cadia, Marta, et al.
Publicado: (2013) -
Agonists and antagonists induce different palonosetron dissociation rates in 5-HT(3)A and 5-HT(3)AB receptors()
por: Lummis, Sarah C.R., et al.
Publicado: (2013) -
Effects of Palonosetron, a 5-HT3 Receptor Antagonist, on Mechanical Allodynia in a Rat Model of Postoperative Pain
por: Jung, Ki Tae, et al.
Publicado: (2013)